Skip to main content

MoneyWorks4Me

Advanced Enzyme Technologies informs about updates on acquisition

19 Nov 2026 Evaluate
With reference to intimation dated August 08, 2026, Advanced Enzyme Technologies has informed that the Company has completed the acquisition of additional stake of 1.22% in JC Biotech Private Limited, subsidiary [JCB] by way of purchase of 2,53,297 Equity Shares from few selling shareholders of JCB, for a consideration of ? 22.80 million i.e. ? 90 per Equity Share. In view of this, the shareholding of the Company in JCB has increased from 95.72% to 96.94% of paid-up share capital of JCB effective from November 18, 2026. Further, the Company is in the process of acquiring the remaining 3.06% equity stake in JCB. Upon completion of the said acquisition, JCB will become a Wholly Owned Subsidiary of the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1885.10
Dr. Reddys Labs. 1390.50
Cipla 1414.95
Lupin 2010.00
Zydus Lifesciences 1195.05
View more..